Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising

Background Direct-to-consumer advertising (DTCA), linked to inappropriate medication use and higher health care expenditures, is the fastest growing form of pharmaceutical marketing. DTCA is legal only in the United States and New Zealand. However, the advent of online interactive social media “Web 2.0” technologies—that is, eDTCA 2.0—may circumvent DTCA legal proscriptions. Objective The purpose of this study was to assess the prevalence of DTCA of leading pharmaceutical company presence and drug product marketing in online interactive social media technologies (eDTCA 2.0). Methods We conducted a descriptive study of the prevalence of eDTCA 2.0 marketing in the top 10 global pharmaceutical corporations and 10 highest grossing drugs of 2009. Results All pharmaceutical companies reviewed (10/10, 100%) have a presence in eDTCA 2.0 on Facebook, Twitter/Friendster, sponsored blogs, and really simple syndication (RSS) feeds. In addition, 80% (8/10) have dedicated YouTube channels, and 80% (8/10) developed health care communication-related mobile applications. For reviewed drugs, 90% (9/10) have dedicated websites, 70% (7/10) have dedicated Facebook pages, 90% (9/10) have health communications-related Twitter and Friendster traffic, and 80% (8/10) have DTCA television advertisements on YouTube. We also found 90% (9/10) of these drugs had a non-corporate eDTCA 2.0 marketing presence by illegal online drug sellers. Conclusion Pharmaceutical companies use eDTCA 2.0 to market themselves and their top-selling drugs. eDTCA 2.0 is also used by illicit online drug sellers. Regulators worldwide must take into account the current eDTCA 2.0 presence when attempting to reach policy and safety goals.

[1]  Daniel P. Lorence,et al.  A Study of the Web as DTC Drug Marketing Agent , 2007, Journal of Medical Systems.

[2]  K. Lyles,et al.  Direct-to-consumer advertising of pharmaceuticals. , 2007, The American journal of medicine.

[3]  R. Sindwani,et al.  Pharmaceutical Marketing and the New Social Media , 2011 .

[4]  T. Mackey,et al.  Reforming direct-to-consumer advertising , 2011, Nature Biotechnology.

[5]  G. DeFriese.  From the New York Times— , 1933, North Carolina medical journal.

[6]  Shoshannah A. Pearlman.  The Patient Protection and Affordable Care Act , 2013, Journal of the American Psychiatric Nurses Association.

[7]  M. Shuchman.  Drug risks and free speech--can Congress ban consumer drug ads? , 2007, The New England journal of medicine.

[8]  J. Fogel,et al.  Direct-to-Consumer Advertisements of Prescription Medications Over the Internet , 2009, Health marketing quarterly.

[9]  B. Kuehn.  FDA weighs limits for online ads. , 2010, JAMA.

[10]  Kurt R. Brekke,et al.  Direct-to-Consumer Advertising in Pharmaceutical Markets , 2005, Journal of health economics.

[11]  Marios C. Angelides,et al.  Implementing the Internet for business: A global marketing opportunity , 1997 .

[12]  Robert L. Swain,et al.  National Association of Boards of Pharmacy , 1954 .

[13]  W. Shrank,et al.  Online Social Networking by Patients with Diabetes: A Qualitative Evaluation of Communication with Facebook , 2011, Journal of General Internal Medicine.

[14]  Julie M Donohue,et al.  A decade of direct-to-consumer advertising of prescription drugs. , 2007, The New England journal of medicine.

[15]  T. Mackey,et al.  Searching for Safety: Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales , 2009, American Journal of Law & Medicine.

[16]  B. Vastag.  US aims to tighten rules on direct-to-consumer drug ads , 2007, Nature Biotechnology.

[17]  T. Mackey,et al.  Confronting Conflict: Addressing Institutional Conflicts of Interest in Academic Medical Centers , 2010, American Journal of Law & Medicine.

[18]  B. Liang.  Parallel Trade in Pharmaceuticals: Injecting the Counterfeit Element into the Public Health , 2006 .

[19]  R. Kravitz,et al.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. , 2010, American journal of public health.

[20]  Y Lamontagne.  [Medical marketing in the media]. , 1991, L'union medicale du Canada.

[21]  Bryan A Liang,et al.  Direct-to-consumer advertising with interactive internet media: global regulation and public health issues. , 2011, JAMA.

[22]  Direct-to-consumer advertising under fire. , 2009, Bulletin of the World Health Organization.

[23]  Richard Toner.  Web 2.0: A New Vocabulary for Health Policy , 2008 .

[24]  S. Majumdar,et al.  Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study , 2008, BMJ : British Medical Journal.

[25]  F. Eugene Yates,et al.  The national center for health statistics , 1973, Annals of Biomedical Engineering.